Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
56
Publications avec texte intégral
Open Access
46 %
Mots clés
Mass cytometry CyTOF
Chronicity
CD31
CXCL13-CXCR5
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Neuromuscular junction
Chronic inflammation
Interferon
Lamin A/C nuclei
PBMC
Follicular hyperplasia
Interféron de type I
Cellules th17
DICER
CCL21
Human myoblasts
B cells
Auto-immunité
Myasthénie grave
Fragile X syndromes
Gender
Immune response
FMR1
Gd T cells
Experimental models
Maladie auto-immune
Macrophages
Germinal centers
COVID-19
AChR antibodies
COX2
Age
Quality of life
Chemokines
Animal models
M3243AG
Interferon de type I
MYB
Long-term follow-up
Genetics
Acides nucléiques endogènes
Myasthenia Gravis MG
Antimir-150
Disease susceptibility
Centres germinatifs ectopiques
Germinal center
Acetylcholine receptors
Immunity
Interferon type I
Thymus
Exercise
Autoimmune diseases
Transcriptome
Th17 cells
Ectopic germinal centers
Cardiomyopathy
Immune regulation
Interleukine-23
Inflammatory cytokines
Innate immunity
Experimental autoimmune myasthenia gravis EAMG
Interferonopathy
Chemokine
Autoimmune disease
Myasthenia gravis
Adaptive immunity
Etiology
Genetic associations
Complete Freund's adjuvant
Interleukin 23
Thymoma
Interferon type-I
Endogenous nucleic acids
Glucocorticoids
Myoblasts
Il-23
Early-onset myasthenia gravis
Thymic epithelial cells
Cytokines
Interferon-β
Ferrites
Inflammation
BAFF
Max
Acetylcholine receptor
Immunotherapy
Heart failure
Clinical cell transplantation
Acetylcholine receptor antibodies
Conduction disease
Interferon IFN
Experimental autoimmune myasthenia gravis
Anticorps monoclonal
Experimental mouse models
Autoimmunity
CTCF
LMNA
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
MG patients
Immunology and Microbiology Section